Mesa Labs completes acquisition of GKE for €85M; expects €19-20M revenue add

MESA LABORATORIES INC /CO/

Acquired GKE sterilization indicators business, SAL GmbH, and agreed to buy GKE China for €85M total.
Financed with $65M from credit facility and $12.6M cash; GKE China close expected in Q3 FY2024.
First 12 months of complete ownership expected to add €19-20M revenue with mid-single-digit organic growth.
Adjusted operating income margin expected to approach 37%-40% for the first 12 months.
Combined SDC division has over 200 distribution partners in 80+ countries.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.